+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID07567222

Phase I Study of a New Vaccine for Safety and Early Effectiveness in Treating Advanced Solid Tumors

Led by West China Hospital · Updated on 2026-06-09

54

Participants Needed

2

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating a novel vaccine made from irradiated tumor cells and stromal cells combined with an adjuvant to address advanced solid tumors. These tumors are challenging to treat due to their complex nature and the immunosuppressive environment around them. This first-in-human Phase I study aims to evaluate the safety and tolerability of this vaccine in patients with various advanced cancers, including osteosarcoma, pancreatic cancer, head and neck, colon, liver, glioma, and triple-negative breast cancer. Participants receive the vaccine through injections, either subcutaneously or into the bone, depending on the cancer type. The vaccination schedule includes a priming phase with doses on Days 0, 14, and 28, followed by booster doses given every 28 days at the investigators discretion. Some participants also receive the drug Regorafenib alongside the vaccine for osteosarcoma. Dose escalation follows a standard 33 design to monitor safety and dose-limiting toxicities at increasing dose levels. During the study, participants are closely monitored for safety and side effects up to six months after the first dose. Researchers assess tumor response, progression-free survival, and overall survival up to 12 months. Blood samples and tumor biopsies are analyzed to observe immune changes and identify markers that could predict response to treatment. The total participation time varies, with ongoing evaluation of participants health and treatment effects throughout the study.

CONDITIONS

Brief Title

Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors

Research Team

X

Xingchen Peng, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here